NCT03530683 · Interventional trial
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
Overall registry status Terminated
Phase 1
Conditions Acute Myeloid Leukemia, Diffuse Large B-Cell Lymphoma, Lymphoma, Multiple Myeloma
Delaware Valley sites
- Sidney Kimmel Cancer Center, Clinical Trials Organization · Philadelphia, PA · Philadelphia County
- Sidney Kimmel Cancer Center, Research Support Services · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University - Clinical Research Institute · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University Investigational Drug Services · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University, Investigational Drug Service · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University, Medical Oncology · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory